"It has been my opinion for a while that the "prospective partners" would not sign a deal until the product achieved EU approvals..."
Almost every pharma deal is done before final trial results. Remember too that TIS already have trial results. It is tried and tested. The new trial is just for market approvals (as they require double blinded results).